Ascendis Health Archives

30 Nov 2017

Ascendis Health announces fully underwritten R750 million rights offer

By Staff Writer

Ascendis Health announced the launch of a fully underwritten renounceable rights offer to raise R750 million to settle a significant portion of the deferred vendor consideration payment owed to the sellers of Remedica Holdings, an international pharmaceutical business acquired in 2016.

12 Oct 2017

Ascendis Earnings up 92% on strong international growth

By Staff Writer

Ascendis Health reported strong growth in normalised headline earnings of 92% to R645 million for the year to June 2017 as the group significantly increased international sales following the completion of three acquisitions in Europe during the year.

12 Jun 2017

Ascendis fortifies its positioning

By Staff Writer

Ascendis Health (Ascendis) recently declared the acquisitions of Sunwave Pharma and NHP Natural Health Pharma (NHP Pharma) unconditional, together with Cipla Agrimed and Cipla Vet.

30 May 2016

Ascendis’ international growth strategy gains momentum

By Staff Writer

Ascendis Health has announced the separate acquisitions of two major European health and care businesses, Remedica Holdings and Scitec International.

17 Aug 2015

Ascendis purchases share of Spanish pharma group

By Staff Writer

Announcing its first international acquisition, Ascendis Health has purchased a 49 per cent stake of Farmalider SA, for R210 million. The deal includes the right to acquire the remainder of the business in two further transactions over the next five years.

22 Jun 2015

New executive director for Ascendis Health

By Staff Writer

Clifford Sampson has been appointed acting managing director at Ascendis Health effective 1 July. Welcoming his appointment, Dr Karsten Wellner, company CEO, comments: ‘We are delighted to have Cliff on our team. As previous MD of Foodcorp he brings a wealth of relevant operational experience and leadership, having worked in both large private and listed corporations for much of his career.’